Guoxin Investment
VC Fund
Guoxin Investment is an investment firm.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 46%
Last updated:
For AI agents: llms.txt
Industries Guoxin Investment invests in
Stages Guoxin Investment invests in
Countries Guoxin Investment invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Lu Zhen
|
|||
Investment Focus
Industry
- Manufacturing 10 (42%)
- Biotechnology 6 (25%)
- Health Care 5 (21%)
- Medical 4 (17%)
- Semiconductor 3 (13%)
Stage
- Series C 8 (33%)
- Series A 3 (13%)
- Series B 3 (13%)
- Series D 3 (13%)
- Series E 3 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Lu Zhen
CEO
|
CEO | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Demark
|
Demark Seiko is a domestic high-end parts supplier that primarily provides high-precision parts, medium and large parts, and functional structural components to firms in the photovoltaic, wind power, semiconductor, heavy industry, and other industries. | $62.2M / Series C / Aug 04, 2026 | |
New Radiomedicine Technology
|
Chengdu New Radiomedicine Technology Co.,Ltd. is a Chinese medical isotopes provider. Our business covers research, manufacture and sales for medical isotopes and products. We provide services for malignant tumor diagnosis and treatments and radionuclides medicine technology support and consulting.In April 2016, the company was founded bythree co-founders experienced in radionuclides research and development. Jihui Qian, former President of Nuclear Power Institute of China (NPIC), former Deputy Director-General of International Atomic Energy Agency (IAEA); Maoliang Li, former Director of Chengdu Isotopes Institute of NPIC; and Jiming Cai, former Vice President of Sichuan Institute of Atomic Energy.The company is located in Western Airport Development District, Shuangliu, Chengdu, with an area of 71 Are, registered capital of 32.83 million CNY, and total investment of 300 million CNY. The project is listed as "Annual Key Investment Projects of Sichuan Province and Chengdu City in 2017, 2018 and 2019". At present, the company has over 80 employees, with more than 60 R&D specialists, including 1 academician of Chinese Academy of Engineering, 2 experts of Thousand Talent Project, 2 academic and technical leaders from Sichuan province, 10 researchers (associate researchers), and more than 20 people with middle or senior titles. Among them, there are 6 PhDs and over 30 graduates. The proportion of R&D staff has reached 70%, making CNRT the most innovative technology enterprise in the radiopharmaceutical industry in China. | $145.4M / Series E / Apr 03, 2026 | |
|
Zhizi Automobile
|
Proton Automobile is a new energy intelligent vehicle developer that concentrates on R&D innovation and sales operations. | Series B / Mar 04, 2026 | |
Kai Medtech
|
Kai Medtech focuses on the research, development, production and sales of neurointerventional implantable medical devices. | Series D / Feb 02, 2026 | |
|
SIMT Nayuan New Materials
|
SIMT Nayuan New Materials is a manufacturer of sodium-electric cathode materials. It focuses on the R&D, production, and sales of sodium-ion battery cathode materials. | Seed / Dec 31, 2025 | |
Metaways
|
Metaways provides research, development, designing, and manufacturing solutions for micro OLED display devices and modules. | $68.5M / Series A / Feb 08, 2025 | |
Fourier Intelligence
|
Fourier Intelligence is a Shanghai-based technology and design company providing exoskeleton robotic product and service on rehabilitation & orthoses. Its products include upper-limb rehab robotics and lower-limb exoskeleton robot, which can help the disabled go beyond of the physical limits, stand up and walk again. Its exoskeleton productscan also decrease fatigue and increase productivity whilst unloading supplies or enabling workers/soldiers to carry heavy objects. | Series E / Jan 07, 2025 | |
Ruicycle
|
Ruicycle is a high-tech company that focuses on the comprehensive recycling and utilization of lithium batteries. | Series C / Aug 24, 2024 | |
Super Silicon Semiconductor
|
Super Silicon Semiconductor focuses on the research and development of parts and materials for silicon integrated circuits. | Series C / Jul 09, 2024 | |
Calterah
|
Calterah engages in the development and design of CMOS process millimeter-wave radar chips. | Series D / Jul 02, 2024 | |
| See all 24 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Guoxin Investment invest in?
Guoxin Investment invests primarily in Manufacturing, Biotechnology and Health Care startups, most often at Series C and Series A stage. Most of the 24 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Guoxin Investment?
Public channels for Guoxin Investment include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Guoxin Investment?
The team at Guoxin Investment includes Lu Zhen (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
